A dominant-negative GFI1B mutation in the gray platelet syndrome

New England Journal of Medicine

Volumn 370, Issue 3, 2014, Pages 245-253

  Monteferrario, Davide ^a   Bolar, Nikhita A ^c   Marneth, Anna E ^a   Hebeda, Konnie M ^b   Bergevoet, Saskia M ^a   Veenstra, Hans ^a   Laros van Gorkom, Britta A P ^b   MacKenzie, Marius A ^b   Khandanpour, Cyrus ^e   Botezatu, Lacramiora ^e   Fransen, Erik ^c,d   Van Camp, Guy ^c   Duijnhouwer, Anthonie L ^b   Salemink, Simone ^b   Willemsen, Brigith ^b   Huls, Gerwin ^a,b   Preijers, Frank ^a   Van Heerde, Waander ^a   Jansen, Joop H ^a   Kempers, Marlies J E ^b   Loeys, Bart L ^c   Van Laer, Lut ^c   Van Der Reijden, Bert A ^a   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA THROMBOGLOBULIN; THROMBOCYTE FACTOR 4;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BLEEDING TENDENCY; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILY; GENE MUTATION; GFI1B GENE; GRAY PLATELET SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LINKAGE ANALYSIS; MEGAKARYOCYTE; MYELOFIBROSIS; NONSENSE MUTATION; PRIORITY JOURNAL; THROMBOCYTOPENIA;

EID: 84892566252     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1308130     Document Type: Article

References (25)

1. Kaushansky K. Historical review: megakaryopoiesis and thrombopoiesis. Blood 2008;111:981-6.
2. Junt T, Schulze H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007;317:1767-70.
3. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001;12:261-73.
4. Maynard DM, Heijnen HF, Horne MK, White JG, Gahl WA. Proteomic analysis of platelet alpha-granules using mass spectrometry. J Thromb Haemost 2007;5:1945-55.
5. Raccuglia G. Gray platelet syndrome: a variety of qualitative platelet disorder. Am J Med 1971;51:818-28.
6. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev 2007;21:21-36.
7. White JG. Ultrastructural studies of the gray platelet syndrome. Am J Pathol 1979;95:445-62.
8. Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, et al. Gray platelet syndrome: natural history of a large patient cohort and locus assignment to chromosome 3p. Blood 2010;116:4990-5001.
9. Weiss HJ, Witte LD, Kaplan KL, et al. Heterogeneity in storage pool deficiency: studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor. Blood 1979;54:1296-319.
10. Breton-Gorius J, Vainchenker W, Nurden A, Levy-Toledano S, Caen J. Defective alpha-granule production in megakaryocytes from gray platelet syndrome: ultrastructural studies of bone marrow cells and megakaryocytes growing in culture from blood precursors. Am J Pathol 1981;102:10-9.
11. Mori K, Suzuki S, Sugai K. Electron microscopic and functional studies on platelets in gray platelet syndrome. Tohoku J Exp Med 1984;143:261-87.
12. Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet á-granules. Nat Genet 2011;43:732-4.
13. Kahr WH, Hinckley J, Li L, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 2011;43:738-40.
14. Albers CA, Cvejic A, Favier R, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet 2011;43:735-7.
15. van der Meer LT, Jansen JH, van der Reijden BA. Gfi1 and Gfi1b: key regulators of hematopoiesis. Leukemia 2010;24:1834-43.
16. Zweidler-Mckay PA, Grimes HL, Flubacher MM, Tsichlis PN. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol Cell Biol 1996;16: 4024-34.
17. Saleque S, Cameron S, Orkin SH. The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev 2002;16:301-6.
18. Randrianarison-Huetz V, Laurent B, Bardet V, Blobe GC, Huetz F, Duménil D. Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-beta signaling at the bipotent erythro-megakaryocytic progenitor stage. Blood 2010;115:2784-95.
19. Khandanpour C, Sharif-Askari E, Vassen L, et al. Evidence that growth factor independence 1b regulates dormancy and peripheral blood mobilization of hematopoietic stem cells. Blood 2010;116: 5149-61.
20. Person RE, Li FQ, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003;34:308-12.
21. Vassen L, Fiolka K, Möröy T. Gfi1b alters histone methylation at target gene promoters and sites of gamma-satellite containing heterochromatin. EMBO J 2006; 25:2409-19.
22. Lee S, Doddapaneni K, Hogue A, McGhee L, Meyers S, Wu Z. Solution structure of Gfi-1 zinc domain bound to consensus DNA. J Mol Biol 2010;397:1055-66.
23. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007;27:562-72.
24. Kurstjens R, Bolt C, Vossen M, Haanen C. Familial thrombopathic thrombocytopenia. Br J Haematol 1968;15:305-17.
25. Vassen L, Fiolka K, Mahlmann S, Möröy T. Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b. Nucleic Acids Res 2005;33:987-98.